-
-
Call more information
660-596-2224 -
Author: Minehart RD et al. Anesthesia & Analgesia 141(3):536–539, September 2025. doi:10.1213/ANE.0000000000007473 This commentary argues that anesthesiologists face escalating cognitive burden from workforce shortages, sicker patients, and a flood of new literature—conditions that increase the risk of cognitive overload, stress, and error-prone decisions. Traditional supports (journals, databases, protocols) help but don’t provide timely, verified “second […]
Read MoreAuthor: Patsy Newitt Becker’s ASC Review In November, Anthem Blue Cross Blue Shield proposed a policy that would have placed time limits on procedures using anesthesia in Missouri, New York and Connecticut. After receiving pushback from patients, physicians, and industry groups, the insurer withdrew the proposal. Similarly, Kaiser Foundation Health Plan walked back a Washington […]
Read MoreAuthor: Khan ZA et al. Anesthesiology, September 10, 2025. doi:10.1097/ALN.0000000000005745 This experimental study investigated how paternal sevoflurane exposure in rats affects the brain-gut-microbiome (BGM) axis across generations. Male rats exposed to sevoflurane prior to mating produced male offspring with significant abnormalities: exaggerated stress responses, hippocampal transcriptomic changes, gut microbiota dysbiosis, systemic inflammation, higher LDL cholesterol, […]
Read MoreHardin Medical Center (122 beds) is offering a rare CRNA-only practice with full autonomy and an unbeatable lifestyle. • Schedule: 2 weeks on / 1 week off (17 weeks off annually)• Model: Independent CRNA practice – no anesthesiologist supervision• Case Mix: General surgery, ortho, endo, OB/GYN (epidurals & C-sections)• No Complex Cases: No hearts, no […]
Read MoreIf you’re an anesthesiologist searching for a balanced lifestyle and rewarding work, you’ll want to check out this opportunity. Our all-anesthesiologist group is seeking a dedicated team member to join our collaborative practice. Position Highlights: Zero Call for 3 Weeks: Enjoy three weeks of no call duty, followed by one week of call. Even during […]
Read MoreAuthor: Francesca Mathewes Becker’s ASC Review Amid mounting reimbursement pressures and rising operational costs, ASC leaders are looking to models for managing anesthesia costs and staffing that will sustain them into the future. Peter Bravos, MD, chief medical officer of Sacramento, Calif.-based Sutter Health’s surgery center division, recently joined Becker’s to discuss the ways that ASCs can […]
Read MoreAuthor: Abramovich I et al. Current Opinion in Anesthesiology 38(5):547–552, October 2025. doi:10.1097/ACO.0000000000001524 This review examines remimazolam—an ultrashort-acting benzodiazepine—in neuroanesthesia. Across recent RCTs and case reports, remimazolam generally produced fewer hypotensive episodes, reduced vasopressor requirements, and allowed faster emergence, especially when flumazenil was used. However, higher BIS values at comparable sedation levels raise monitoring accuracy […]
Read MoreAuthor: Goh G et al. Anaesthesia Critical Care & Pain Medicine, 2025. doi:10.1016/j.accpm.2025.101591 This multicenter retrospective cohort from 12 Queensland ICUs (2015–2021) evaluated ICU-acquired metabolic alkalosis. Among 24,676 eligible adult admissions (ICU LOS >48 h; no alkalosis in first 24 h), 36% (n=8,889) developed alkalosis, typically on day 4 (IQR 3–6). Diuretics (28%) and steroids […]
Read MoreAuthor: Francesca Mathewes Becker’s ASC Review Private equity’s presence in anesthesia has been the subject of several recent lawsuits and studies on healthcare costs as the specialty becomes increasingly consolidated. Here are eight notes private equity group’s recent moves in anesthesia: 1. A study published in July by the University of Chicago’s Booth School of Business found that anesthesia costs […]
Read MoreAuthor: Adelmann D et al. Anesthesiology, September 18, 2025. doi:10.1097/ALN.0000000000005759 This multicenter observational study evaluated the TEG® 6s Global Hemostasis – Heparin Neutralization cartridge, newly cleared by the FDA, in patients undergoing cardiovascular surgery with cardiopulmonary bypass (CPB) or other invasive cardiac procedures requiring unfractionated heparin. A total of 543 blood samples from 185 patients […]
Read More